Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-01-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aminophylline for Patients With Post-Dural Puncture Headache
NCT02522013
Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache
NCT02394457
Establishment of a Predictive Model for Post-dural Puncture Headache
NCT06800859
Bupivacaine for Benign Headache in the ED
NCT01785459
Sphenopalatine Blockade Versus Clinical Treatment
NCT04148846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
IV caffeine with saline and opiate
Caffeine
Caffeine 500 mg IV
2
IV saline with opiate
saline
Normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caffeine
Caffeine 500 mg IV
saline
Normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnant
* allergic to caffeine
* cardiac or peripheral vascular disease
* uncontrolled hypertension
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Naval Medical Center, Portsmouth
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A Kostic, MD
Role: STUDY_CHAIR
United States Naval Medical Center, Portsmouth
Marcelo Darabos, MD
Role: PRINCIPAL_INVESTIGATOR
United States Naval Medical Center, Portsmouth
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emergency Department, Naval Medical Center Portsmouth
Portsmouth, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP 2006 0051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.